Research progress of nuclear factor-kappa B and alcoholic liver disease

[5]Cheng Q, Lee HH, Li Y, et a1.Upregulation of Bcl-x and Bfl-1as a potential mechanism of ehemoresistance, which can be over-come by NF-kappa B inhibition[J].Oncogene, 2000, 19 (42) ∶4936-4940.

[6]Wang CY, Guttridge DC, Mayo MW, et a1.NF-kappa B induces expression of Bcl-2homologue A1/Bf-1to preferentially suppress chemotherapy induced apoptosis[J].Mol Cell Biol, 1999, 19 (9) ∶5923-5929.

[7]Tumang JR, Hsia CY, Tian W, et a1.IL-6rescues the hypore-sponsi veness of c-Rel deficient B cells independent of Bcl-xl, Mcl-1, and Bcl-2[J].Cell Immunol, 2002, 217 (1-2) ∶47-57.

[8]崔香丹, 金武丕, 李香.大鼠酒精性肝病细胞凋亡中Caspase-3、NF-κB的表达[J].陕西医学杂志, 2009, 38 (3) ∶273-275.

[9]Hock JB, Pastofino JG.Ethanol, oxidative stress, and cytokine-induced liver cell injury[J].A1cohol, 2002, 27 (1) ∶63-68.

[10]Kono H, Rusyn I, Uesugi T, et al.Diphenyleneiodonium sulfate, an NADPHoxidase inhibitor, prevents early alcohol-induced liver injury in the rat[J].Am J Physiol Gastrointest Liver Physiol, 2001, 280 (5) ∶1005-1012.

[11]TomZ, Marta K.Oxidative stress and signal transduction path-ways in alcoholic liver disease[J].Clinical and experimental, 2006, 29 (11) ∶110-115.

[12]Zamara E, Novo E, Marra F, et al.4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells[J].J Hepatol, 2004, 40 (1) ∶60-68.

[13]Kai OL, Kalle J, Amin A.Acetaldehyde Prevents Nuclear Factor-Kappa B Activation and Hepatic Inflammation in Ethanol-Fed Rats[J].Laboratroy investigation, 1999, 79 (7) ∶799-806.

[14]Fernandez MA, Callejas NA, Casado M, et al.Thioacetamide-in-duced liver regeneration involves the expression of cyclooxygenase2and nitric oxide synthase2in hepatocytes[J].J Hepatol, 2004, 40 (6) ∶963-970.

[15]陈科全, 周字.核因子NF-κB与肝纤维化的关系研究现状[J].国际消化病杂志, 2007, 27 (1) ∶9-12.

[16]Istvan H, Pranoti M, Arumugam V, et al.The Critical Role of Toll-Like Receptor (TLR) 4in Alcoholic Liver Disease Is Independ-ent of the Common TLR Adapter MyD88[J].Hepatology, 2008, 48 (4) ∶1224-1229.

[17]Uesugi T, Froh M, Arteel GE, et al.Toll-like receptor4is in-volved in the mechanism of early alcohol-induced liver injury in mice[J].Hepatology, 2001, 34 (1) ∶101-108.

[18]Wheeler MD, Katuna M, Smutney M, et al.Comparison of the effect of adenoviral delivery of three superoxide dismutase genes a-gainst hepatic ischemia-reperfusion injury[J].Human gene thera-py, 2001, 12 (18) ∶2167-2177.

[19]Stewart SF, Day CP.The management of alcoholic liver disease[J].J Hepatol, 2003, 38 (1) ∶2-13.

[20]范建高, 丁晓东.酒精性肝炎的治疗现状[J].中华肝脏病杂志, 2003, 11 (11) ∶703-704.

Relative Articles

[1]	Boyuan GU, Shengyou XIAO, Chen LIU, Yonglang CHENG, Wenguang FU. Research advances in the role of Enterococcus faecalis in alcoholic liver disease[J]. Journal of Clinical Hepatology, 2023, 39(7): 1696-1702. doi: 10.3969/j.issn.1001-5256.2023.07.026
[2]	Tiantian LIU, Jiangkai LIU, Suling LI, Liang LIU, Yaru ZHANG, Jianwen ZHANG, Bingqian LI. Advances in the mechanism of action of silent information regulator 1 in alcoholic liver disease and related pharmaceutical studies[J]. Journal of Clinical Hepatology, 2022, 38(12): 2841-2845. doi: 10.3969/j.issn.1001-5256.2022.12.030
[3]	Zixiang GAO, Zhongliang SHEN, Jing LIU, Youhua XIE. Research advances in cytokines in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2022, 38(8): 1710-1715. doi: 10.3969/j.issn.1001-5256.2022.08.002
[4]	Weihong LIU, Lei LI. Advances in chronic hepatitis B with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(12): 2905-2908. doi: 10.3969/j.issn.1001-5256.2021.12.035
[5]	Qian WANG, Chunyan CHANG, Song YANG. Research advances in alcoholic liver disease with sarcopenia[J]. Journal of Clinical Hepatology, 2021, 37(8): 1943-1947. doi: 10.3969/j.issn.1001-5256.2021.08.043
[6]	Gege TIAN, Enrui XIA, Suyan ZHANG, Shunzhen ZHAGN, Furong XU. Research advances in traditional Chinese medicine in improving nonalcoholic steatohepatitis by regulating the Toll-like receptor 4/nuclear factor-kappa B signaling pathway[J]. Journal of Clinical Hepatology, 2021, 37(12): 2957-2962. doi: 10.3969/j.issn.1001-5256.2021.12.047
[7]	Zheng Yang, Wang JiaRu, Liu LuLu, Wang JiaHui, Zhao TieJian. Molecular mechanism of the anti-liver fibrosis effect of curcumol: An analysis based on the TLR4/NF-κB signaling pathway[J]. Journal of Clinical Hepatology, 2020, 36(7): 1508-1513. doi: 10.3969/j.issn.1001-5256.2020.07.013
[8]	Sun TingTing, Li JingTao, Wei HaiLiang, Yan ShuGuang, Li Qian, Guo YingJun, Chang ZhanJie. Research advances in the role of the TNF-α/NF-κB signaling pathway in the regulation of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2019, 35(9): 2095-2098. doi: 10.3969/j.issn.1001-5256.2019.09.047
[10]	Cao Dan, Chen WenJing, Li YanPing, Chen YanPing. Research advances in chronic hepatitis B complicated by nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2018, 34(9): 1986-1989. doi: 10.3969/j.issn.1001-5256.2018.09.033
[11]	Xia Geng, Qi Fei, Yang JinHui, Tang YingMei, Shi MengLin, Zhang JunQi. Expression of nuclear factor-kappa B p65 in hepatocellular carcinoma and its significance[J]. Journal of Clinical Hepatology, 2017, 33(12): 2342-2345. doi: 10.3969/j.issn.1001-5256.2017.12.017
[12]	Liu LuLu, Ren Yi, He YiHuai, Lin ShiDe. Research advances in chronic hepatitis B complicated by nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(3): 538-542. doi: 10.3969/j.issn.1001-5256.2017.03.032
[14]	Tan YanGuo, Yan HuiPing, Gao ZuHua. Research progress in role of B cell immunity in primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(5): 400-404. doi: 10.3969/j.issn.1001-5256.2014.05.004
[15]	Nan YueMin, Mi HongMei, Du JingHua, Wang RongQi, Kong LingBo, Ren WeiGuang, Li Hui, Zhao SuXian. Role and molecular mechanism of HO-1-mediated NF-κB modulation in fibrosis progression of nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2013, 29(5): 375-378.
[16]	Qiao ChunPing, Chen YueXiang. Advances in study of the relationship between apoptosis and alcoholic liver disease[J]. Journal of Clinical Hepatology, 2012, 28(5): 386-390.
[17]	Lu XiaoJu, Chen YongPing, Yang Tao, Shen ChunYan. Effect of baicalin of the expression of NF-κB in acute liver failure in rats[J]. Journal of Clinical Hepatology, 2011, 27(10): 1087-1092.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (3108) PDF downloads(686)

Research progress of nuclear factor-kappa B and alcoholic liver disease

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Research progress of nuclear factor-kappa B and alcoholic liver disease

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content